Home ProductsNootropic Powder

Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9

Certification
Good quality Peptide APIs for sales
Good quality Peptide APIs for sales
Customer Reviews
Good Price .Product is by far the besT, very pleased and happy, wil buy again.

—— K******s United Kingdom

High Purity, fast shipping ,recomended this company.

—— Perry*****t United State

Great service I was kept informed about my order the whole time Thanks Jones.

—— E****y Australia

I'm Online Chat Now

Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9

China Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9 supplier
Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9 supplier Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9 supplier

Large Image :  Effective 99% Assay Tofacitinib Citrate API Powder CAS Number 540737-29-9

Product Details:

Place of Origin: China
Brand Name: MOBELBIO
Certification: ISO.SGS

Payment & Shipping Terms:

Minimum Order Quantity: 100 grams
Price: 1
Packaging Details: 1kgs/Bag
Delivery Time: Within 1-3 Days
Payment Terms: T/T
Supply Ability: 50kgs/Month
Contact Now
Detailed Product Description

Product name Tofacitinib powder
CAS NO. 477600-75-2
  3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; 3-{(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; CP 690550
MW 312.3696
MF C16H20N6O
Application New oral drugs for the occasional method, (tofacitinib the introduction) to selectively inhibit JAK3 signal transduction pathways in cells, inhibition of CD4 T cell proliferation, further blocking interleukin (IL) 17, a gamma interferon, IL - 6, IL - 8 synthesis and secretion of cytokines, such as inhibition of patients with RA synovial fibroblasts proliferation and damaged cartilage further damage.Jak kinase inhibitors, the treatment of rheumatoid arth
Standard purity:>99%
Appearance White powder
Shelf life 2 yares

 

Tofacitinib (INN) is a drug of the janus kinase (JAK) inhibitor class, discovered and developed by the National Institutes of Health and Pfizer. Tofacitinib is marketed as Xeljanz and Jakvinus.

It is currently approved for the treatment of rheumatoid arthritis (RA) in the United States and other countries.

It has demonstrated effectiveness in the treatment of psoriasis in Phase 3 studies. It is being studied for treatment of inflammatory bowel disease, and other immunological diseases, as well as for the prevention of organ transplant rejection.

Contact Details
HANGZHOU MOBEL BIOTECHNOLOGY CO.,LTD

Contact Person: admin

Send your inquiry directly to us (0 / 3000)